Increased length-dependent activation of human engineered heart tissue after chronic α1A-adrenergic agonist treatment: testing a novel heart failure therapy
* Corresponding Author; email: [email protected]
1Veterans Affairs Medical Center, San Francisco, and Department of Medicine, University of California San Francisco, San Francisco, CA, United States
2Department of Internal Medicine, Division of Cardiovascular Medicine, University of California Davis, Sacramento, CA, United States
Comments (0)